Resecting MRI-Detected Disease Doesn’t Improve Outcomes in Early-Stage BC

Surgical resection of MRI-detected disease may not be required in the context of systemic therapy and radiation therapy in patients with early-stage breast cancer, according to results from the phase 3 Alliance A011104/ACRIN 6694 trial…

Continue Reading